Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8271)
All Articles published online
|
Dec 6, 2012 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Canavesi E, Alfieri C, Pelusi S, Valenti L. Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease. World J Nephrol 2012; 1(6): 166-176 [PMID: 24175256 DOI: 10.5527/wjn.v1.i6.166] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v1/i6/166.htm |
| Number | Citing Articles |
| 1 |
Р.А. АРИНГАЗИНА, С.С. САПАРБАЕВ, А. АМАНЖОЛКЫЗЫ, Г.К. ГУБАШЕВА, Н.Ж. ЖОЛДАСОВА. ЖҮКТІ ӘЙЕЛДЕРДЕГІ ТЕМІРТАПШЫЛЫҚ АНЕМИЯ ЖӘНЕ СОЗЫЛМАЛЫ АУРУЛАРДЫҢ АНЕМИЯСЫНЫҢ ДАМУЫНДАҒЫ ГЕПСИДИННІҢ РӨЛІ (ӘДЕБИЕТТЕРГЕ ШОЛУ). Vestnik 2022; (3(62)): 88 doi: 10.53065/kaznmu.2022.71.66.009
|
| 2 |
Luca Valenti, Alessandro Maloberti, Stefano Signorini, Marta Milano, Francesca Cesana, Fabrizio Cappellini, Paola Dongiovanni, Marianna Porzio, Francesco Soriano, Maura Brambilla, Giancarlo Cesana, Paolo Brambilla, Cristina Giannattasio, Silvia Fargion, Kostas Pantopoulos. Iron Stores, Hepcidin, and Aortic Stiffness in Individuals with Hypertension. PLOS ONE 2015; 10(8): e0134635 doi: 10.1371/journal.pone.0134635
|
| 3 |
Jürgen Floege, Felix Funk, Markus Ketteler, Anjay Rastogi, Sebastian Walpen, Adrian C Covic, Stuart M Sprague. Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation. Nephrology Dialysis Transplantation 2020; 35(6): 946 doi: 10.1093/ndt/gfaa030
|
| 4 |
Gerhard Rogler, Stephan Vavricka. Anemia in Inflammatory Bowel Disease: An Under-Estimated Problem?. Frontiers in Medicine 2015; 1 doi: 10.3389/fmed.2014.00058
|
| 5 |
Chen Yueying, Wang Yu Fan, Shen Jun. Anemia and iron deficiency in Crohn’s disease. Expert Review of Gastroenterology & Hepatology 2020; 14(3): 155 doi: 10.1080/17474124.2020.1732817
|
| 6 |
J. C. Fernandes, P. Garrido, S. Ribeiro, P. Rocha-Pereira, E. Bronze-da-Rocha, L. Belo, E. Costa, F. Reis, A. Santos-Silva. Iron as the Key Modulator of Hepcidin Expression in Erythroid Antibody-Mediated Hypoplasia. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/421304
|
| 7 |
Zeki Aydin, Meltem Gursu, Serhat Karadag, Sami Uzun, Abdullah Sumnu, Yasemin Doventas, Savas Ozturk, Rumeyza Kazancioglu. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study. Renal Failure 2014; 36(8): 1253 doi: 10.3109/0886022X.2014.937663
|
| 8 |
Sandra Ribeiro, Luís Belo, Flávio Reis, Alice Santos-Silva. Iron therapy in chronic kidney disease: Recent changes, benefits and risks. Blood Reviews 2016; 30(1): 65 doi: 10.1016/j.blre.2015.07.006
|
| 9 |
Patrícia Garrido, Sandra Ribeiro, João Fernandes, Helena Vala, Petronila Rocha-Pereira, Elsa Bronze-da-Rocha, Luís Belo, Elísio Costa, Alice Santos-Silva, Flávio Reis. Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia. International Journal of Molecular Sciences 2015; 17(1): 28 doi: 10.3390/ijms17010028
|
| 10 |
Ashwani K Gupta, Waseem David, Zoran Ivanovic. Does Erythropoietin Cause Hemoglobin Variability- Is It ‘Normal’?. PLoS ONE 2014; 9(4): e92890 doi: 10.1371/journal.pone.0092890
|
| 11 |
Adrian C. Covic, Jürgen Floege, Markus Ketteler, Stuart M. Sprague, Laura Lisk, Viatcheslav Rakov, Anjay Rastogi. Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide. Nephrology Dialysis Transplantation 2016; : gfw242 doi: 10.1093/ndt/gfw242
|
| 12 |
Osama Nady Mohamed, Ahmed Mohamed Mady, Mohamed Mamdouh Sedik, Ahmed S. Issa, Omima M. Mohamed, Nadia Ismail Abdelhameed. The relationship between asymptomatic atherosclerosis and hepcidin-25 in chronic kidney disease patients. Annals of Saudi Medicine 2023; 43(5): 298 doi: 10.5144/0256-4947.2023.298
|
| 13 |
Luca Valenti, Serena Pelusi. HFE mutations and iron in hemodialysis patients. Hemodialysis International 2017; 21(S1) doi: 10.1111/hdi.12541
|
| 14 |
Junichi Fujii. Ascorbate is a multifunctional micronutrient whose synthesis is lacking in primates. Journal of Clinical Biochemistry and Nutrition 2021; 69(1): 1 doi: 10.3164/jcbn.20-181
|
| 15 |
Junichi Fujii, Tsukasa Osaki, Tomoki Bo. Ascorbate Is a Primary Antioxidant in Mammals. Molecules 2022; 27(19): 6187 doi: 10.3390/molecules27196187
|
| 16 |
Norio Suzuki, Masayuki Yamamoto. Roles of renal erythropoietin-producing (REP) cells in the maintenance of systemic oxygen homeostasis. Pflügers Archiv - European Journal of Physiology 2016; 468(1): 3 doi: 10.1007/s00424-015-1740-2
|
| 17 |
Dalila Cunha Oliveira, Amanda Nogueira-Pedro, Ed Wilson Santos, Araceli Hastreiter, Graziela Batista Silva, Primavera Borelli, Ricardo Ambrósio Fock. A review of select minerals influencing the haematopoietic process. Nutrition Research Reviews 2018; 31(2): 267 doi: 10.1017/S0954422418000112
|
| 18 |
Violeta Dopsaj, Aleksandra Topić, Miljan Savković, Neda Milinković, Ivana Novaković, Danica Ćujić, Sanja Simić-Ogrizović. Associations of Common Variants in HFE and TMPRSS6 Genes with Hepcidin-25 and Iron Status Parameters in Patients with End-Stage Renal Disease. Disease Markers 2019; 2019: 1 doi: 10.1155/2019/4864370
|
| 19 |
Alexandre Reuben, Jacqueline W. Chung, Réjean Lapointe, Manuela M. Santos. The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune system. Immunity, Inflammation and Disease 2017; 5(3): 218 doi: 10.1002/iid3.158
|
| 20 |
Kristina Petrulienė, Edita Žiginskienė, Vytautas Kuzminskis, Irena Nedzelskienė, Inga Arūnė Bumblytė. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Medicina 2017; 53(2): 90 doi: 10.1016/j.medici.2017.03.001
|
| 21 |
Lucile Mercadel, Marie Metzger, Jean Philippe Haymann, Eric Thervet, Jean-Jacques Boffa, Martin Flamant, François Vrtovsnik, Pascal Houillier, Marc Froissart, Bénédicte Stengel, Jaap A. Joles. The Relation of Hepcidin to Iron Disorders, Inflammation and Hemoglobin in Chronic Kidney Disease. PLoS ONE 2014; 9(6): e99781 doi: 10.1371/journal.pone.0099781
|
| 22 |
HUADING LU, LIYI LIAN, DEHAI SHI, HUIQING ZHAO, YUHU DAI. Hepcidin promotes osteogenic differentiation through the bone morphogenetic protein 2/small mothers against decapentaplegic and mitogen-activated protein kinase/P38 signaling pathways in mesenchymal stem cells. Molecular Medicine Reports 2015; 11(1): 143 doi: 10.3892/mmr.2014.2769
|
| 23 |
Rumaisa Riaz, Taruba Rais, Afsheen Khan, Qazi Shurjeel, Aymar Akilimali. Unlocking the potential of Jesduvroq: a novel approach to anemia management in chronic kidney disease: an editorial. International Journal of Surgery: Global Health 2023; 6(6) doi: 10.1097/GH9.0000000000000368
|
| 24 |
Han Li, Su-Juan Feng, Lu-Lu Su, Wei Wang, Xiao-Dong Zhang, Shi-Xiang Wang. Serum Hepcidin Predicts Uremic Accelerated Atherosclerosis in Chronic Hemodialysis Patients with Diabetic Nephropathy. Chinese Medical Journal 2015; 128(10): 1351 doi: 10.4103/0366-6999.156781
|
| 25 |
Junichi Fujii, Takujiro Homma, Sho Kobayashi, Prashant Warang, Manisha Madkaikar, Malay B. Mukherjee. Erythrocytes as a preferential target of oxidative stress in blood. Free Radical Research 2021; 55(8): 781 doi: 10.1080/10715762.2021.1873318
|